Monday 2 November 2026 Export CL’s income statement to Excel — free account

Colgate-Palmolive Company

CL Consumer Defensive Household & Personal Products

Colgate-Palmolive Company’s revenue for fiscal 2025 (year ended December 2025) was $20.4 billion, up 1.40% from fiscal 2024.

Revenue: +4.64%
EPS: +7.42%
Free cash flow: −6.24%
Total debt: −8.35%

Quarter to September 2026, against a year earlier

97.62 2.33 +2.45%

Follow CL

Alert me

Market cap: $76.0B
P/E: 37.4×
Fwd P/E: 26.3×
Dividend yield: 2.16%
F-score: 6/9
Altman Z: 6.51
Beneish M: −3.04
Dividend safety: 66/100

Overview Business Profile Earnings & Analysis Segments Filings

Colgate-Palmolive Company (CL) revenue by segment, product and region

Where the money comes from and where it goes

Fiscal 2025: revenue by segment, and margins
Oral, Personal and Home Care	15,769	77.37%
Hill's Pet Nutrition	4,613	22.63%
Gross margin		60.11%
Operating margin		16.22%
Pre-tax margin		15.01%

Revenue by segment $m

Line	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011
Oral, Personal and Home Care	15,769 77.37%	15,618 77.70%	15,167 77.95%	14,254 79.33%	14,110 80.99%	13,588 82.50%	13,168 83.91%	13,156 84.64%	13,162 85.17%	12,931 85.10%	13,822 86.20%	15,022 86.95%	15,209 87.31%	14,925 87.36%	14,562 87.02%
Hill's Pet Nutrition	4,613 22.63%	4,483 22.30%	4,290 22.05%	3,713 20.67%	3,311 19.01%	2,883 17.50%	2,525 16.09%	2,388 15.36%	2,292 14.83%	2,264 14.90%	2,212 13.80%	2,255 13.05%	2,211 12.69%	2,160 12.64%	2,172 12.98%
Revenue	20,382	20,101	19,457	17,967	17,421	16,471	15,693	15,544	15,454	15,195	16,034	17,277	17,420	17,085	16,734

Operating income by segment $m, and margin

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011
Oral, Personal and Home Care	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Hill's Pet Nutrition	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Corporate and other	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Operating income	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡

Operating figures as reported in each quarter’s results release or filing

Figure	Quarter	Latest	A year before	Change
As Reported Volume	Q4 FY2025	1.10%	11.5%	—
As Reported Volume	Q3 FY2026	1.90%	−3.50%	—
As Reported Volume	Q4 FY2025	0.80%	1.70%	—
As Reported Volume	Q3 FY2026	1.80%	−2.60%	—
As Reported Volume	Q3 FY2026	3.90%	−1.90%	—
As Reported Volume	Q3 FY2026	−3.70%	−0.50%	—
As Reported Volume	Q3 FY2026	1.70%	−1.50%	—
Organic Volume	Q1 FY2026	0.60%	—	—
Pricing	Q3 FY2026	2.10%	3.60%	—
Pricing	Q4 FY2025	9.10%	−2.10%	—
Pricing	Q3 FY2026	2.00%	2.30%	—
Pricing	Q3 FY2026	2.80%	2.50%	—
Pricing	Q3 FY2026	2.20%	0.10%	—
Pricing	Q3 FY2026	−0.90%	0.40%	—
Pricing	Q3 FY2026	3.90%	—	—
Pricing	Q3 FY2026	1.40%	—	—

	Q3 FY2026	Q1 FY2026	Q4 FY2025	Q3 FY2025	Q4 FY2024	Q2 FY2024	Q1 FY2024	Q4 FY2023	Q3 FY2023
As Reported Volume	‡	‡	‡	‡	‡	‡	‡	‡	‡
As Reported Volume	‡	‡	‡	‡	‡	‡	‡	‡	‡
As Reported Volume	‡	‡	‡	‡	‡	‡	‡	‡	‡
As Reported Volume	‡	‡	‡	‡	‡	‡	‡	‡	‡
As Reported Volume	‡	‡	‡	‡	‡	‡	‡	‡	‡
As Reported Volume	‡	‡	‡	‡	‡	‡	‡	‡	‡
As Reported Volume	‡	‡	‡	‡	‡	‡	‡	‡	‡
Organic Volume	‡	‡	‡	‡	‡	‡	‡	‡	‡
Pricing	‡	‡	‡	‡	‡	‡	‡	‡	‡
Pricing	‡	‡	‡	‡	‡	‡	‡	‡	‡
Pricing	‡	‡	‡	‡	‡	‡	‡	‡	‡
Pricing	‡	‡	‡	‡	‡	‡	‡	‡	‡
Pricing	‡	‡	‡	‡	‡	‡	‡	‡	‡
Pricing	‡	‡	‡	‡	‡	‡	‡	‡	‡
Pricing	‡	‡	‡	‡	‡	‡	‡	‡	‡
Pricing	‡	‡	‡	‡	‡	‡	‡	‡	‡

As each company reports them in its 10-K and 10-Q filings, in US dollars. Where a later filing recast a year's segments, the year is shown as recast; a period whose breakdown does not add up to the company's revenue is left out.